- Consumers Can Apply Today for a Chance to be Featured in an
Upcoming Campaign by Natrelle® and Share Their Personal
Stories.
- Natrelle® is the #1 Selected Breast Implant by
Leading U.S. Physicians* Offering the Largest Range of
Options For Every Curve, Every Shape, For Every BODY.
IRVINE,
Calif., Feb. 6, 2025 /PRNewswire/ -- Allergan
Aesthetics, an AbbVie company (NYSE: ABBV), announced a
nationwide open casting call in search of the next Faces of
Natrelle®, encouraging women who have experienced
breast reconstruction and/or augmentation to share their inspiring
stories and be featured in the brand's upcoming campaign. As an
extension of the Natrelle® For Every
BODY platform launched last year, the initiative continues to
strengthen the company's commitment to foster an inclusive and
diverse space where all women feel seen and valued.
"The Faces of Natrelle® campaign is more than
just celebrating physical beauty," said Carrie Strom, Senior Vice President, AbbVie and
President, Global Allergan Aesthetics. "We're honoring the
strength, resilience, and uniqueness of the women who use our
products. Through this campaign, our goal is to empower women who
are considering breast surgery by demystifying treatment,
encouraging transparency, and celebrating the diversity of every
curve, every shape, and every BODY."
The Faces of Natrelle® casting call is open
now through February 28, 2025 closing
at 11:59 p.m. EDT. Women 22 years of
age or older who have recently scheduled or undergone a
Natrelle® breast augmentation or reconstruction
are encouraged to learn more about eligibility and how to apply at
Faces.Natrelle.com. Intended for U.S. audiences only. The final
cast will be announced later this year.
To learn more about treatment with Natrelle®
or to find a provider, please visit natrelle.com, and follow
along on Instagram @natrellebreastaugmentation and
@natrellebreastreconstruction.
*Based on surgeon survey data, January
2021 (N = 114) and Plastics Monthly Tracker DOF Jan. 2021.
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION AND APPROVED USES
Breast implants are not considered lifetime devices. The
longer people have them, the greater the chances are that they will
develop complications, some of which will require more
surgery.
Breast implants have been associated with the development of
a cancer of the immune system called breast implant–associated
anaplastic large cell lymphoma (BIA-ALCL). This cancer occurs more
commonly in patients with textured breast implants than smooth
implants, although rates are not well defined. Some patients have
died from BIA-ALCL.
Patients receiving breast implants have reported a variety of
systemic symptoms, such as joint pain, muscle aches, confusion,
chronic fatigue, autoimmune diseases, and others. Individual
patient risk for developing these symptoms has not been well
established. Some patients report complete resolution of symptoms
when the implants are removed without replacement.
Who can get breast implants?
Natrelle® Breast Implants are approved
for the following:
- Breast augmentation for women at least 22 years old
for silicone-filled implants and for women at least 18 years old
for saline-filled implants. Breast augmentation includes
primary breast augmentation to increase the breast size and
revision surgery to correct or improve the result of a primary
breast augmentation
- Breast reconstruction. This includes primary breast
reconstruction to replace breast tissue that has been removed due
to cancer or trauma or that has failed to develop properly due to a
severe breast abnormality. This also includes revision surgery to
correct or improve the result of a primary breast
reconstruction
Who should NOT get breast implants?
Breast implant surgery should NOT be performed in:
- Women with active infection anywhere in their body
- Women with existing cancer or precancer of their breast who
have not received adequate treatment for those conditions
- Women who are currently pregnant or nursing
What should I tell my doctor?
Tell your doctor if you have any of the following conditions, as
the risks of breast implant surgery may be higher:
- Autoimmune diseases (eg, lupus and scleroderma)
- A weakened immune system (eg, taking medications to decrease
the body's immune response)
- Planned chemotherapy or radiation therapy following breast
implant placement
- Conditions or medications that interfere with wound healing and
blood clotting
- Reduced blood supply to breast tissue
- Clinical diagnosis of depression or other mental health
disorders, including body dysmorphic disorder and eating
disorders
- Those with a diagnosis of depression or other mental health
disorders should wait for resolution or stabilization of these
conditions prior to undergoing breast implantation surgery
What else should I consider?
- There is a Boxed Warning for breast implants. Please see bold
text at beginning
- Many changes to your breasts following implantation are
irreversible. If you later choose to have your implants removed and
not replaced, you may experience dimpling, puckering, wrinkling, or
other cosmetic changes, which may be permanent
- Breast implantation is likely not a one-time surgery. The
longer implants are in place, the greater the potential risk for
complications. You will likely need additional surgeries on your
breasts due to complications or unacceptable cosmetic results.
Thus, you should also consider the complication rates for later
(revision) surgery since you may experience these risks in the
future
- Cancer treatments and surgery will affect the outcome and
timing of breast reconstruction
- Breast implants may affect your ability to breastfeed, either
by reducing or eliminating milk production
- Rupture of a silicone-filled breast implant is most often
silent. Even if you have no symptoms, you should have your first
ultrasound or MRI at 5 to 6 years after your initial implant
surgery and then every 2 to 3 years thereafter regardless of
whether your implants are for augmentation or reconstruction. If
you have symptoms of or uncertain ultrasound results for breast
implant rupture, an MRI is recommended. Additional imaging may be
required depending on your medical history and status. The health
consequences of a ruptured silicone gel-filled breast implant have
not been fully established
- Routine screening mammography for breast cancer will be more
difficult, and implants may rupture during the procedure. Perform
self-examination every month for cancer screening and ask your
surgeon to help you distinguish the implant from your breast
tissue. Lumps, persistent pain, swelling, hardening, or changes in
implant shape should be reported to your surgeon and possibly
evaluated with imaging
What are key complications with breast implants?
Key
complications include reoperation, implant removal with or without
replacement, implant rupture with silicone-filled implants, implant
deflation with saline-filled implants, and capsular contracture
(severe scar tissue around the implant). Other complications
include breast pain, swelling, asymmetry, wrinkling/rippling,
implant malposition nipple complications, hypertrophic scarring,
and implant palpability/visibility.
Talk to your doctor about other complications.
For more information, see the patient brochures at
www.allergan.com/products.
To report a problem with Natrelle® Breast
Implants, please call Allergan® at
1-800-624-4261.
The sale and distribution of Natrelle® Breast
Implants is restricted to licensed physicians who provide
information to patients about the risks and benefits of breast
implant surgery.
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture,
and market a portfolio of leading aesthetics brands and products.
Our aesthetics portfolio includes facial injectables, body
contouring, plastics, skin care, and more. Our goal is to
consistently provide our customers with innovation, education,
exceptional service, and a commitment to excellence, all with a
personal touch. For more information, visit
www.allerganaesthetics.com.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
and solutions that solve serious health issues today and address
the medical challenges of tomorrow. We strive to have a remarkable
impact on people's lives across several key therapeutic areas –
immunology, oncology, neuroscience, and eye care – and products and
services in our Allergan Aesthetics portfolio. For more information
about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
LinkedIn, Facebook, Instagram, X (formerly Twitter), and
YouTube.
Contacts
Allergan Aesthetics Media:
Ember Garrett
+1 (949) 413-6091
Garrett_ember@allergan.com
AbbVie Investors:
Liz Shea
+1 (847) 935-2211
Liz.Shea@abbvie.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/allergan-aesthetics-invites-consumers-to-join-the-faces-of-natrelle-campaign-302369295.html
SOURCE AbbVie
